BCI
ABBV icon

Blue Capital Inc’s AbbVie ABBV Stock Holding History

Blue Capital Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$513K Buy
2,361
+573
+32% +$127K 0.34% 70
2025
Q4 		$409K Buy
1,788
+14
+0.8% +$3.19K 0.29% 66
2025
Q3 		$411K Buy
1,774
+104
+6% +$21.2K 0.31% 67
2025
Q2 		$310K Buy
+1,670
New +$310K 0.22% 69
2024
Q4 		$297K Buy
+1,670
New +$307K 0.21% 90

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Blue Capital Inc's ABBV Position: Q1 2026 in Review

Blue Capital Inc increased its AbbVie (ABBV) stake by 32% in Q1 2026, buying an estimated $127K and bringing the position to 2,361 shares worth $513K. The position accounts for 0.34% of the portfolio, ranked #70.

Blue Capital Inc first reported a position in ABBV in Q4 2024 and has held it in 5 quarters since. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Blue Capital Inc held 2,361 shares of AbbVie worth $513K as of Q1 2026.
  • Blue Capital Inc bought 573 AbbVie shares in Q1 2026, an estimated $127K.
  • AbbVie made up 0.34% of Blue Capital Inc's portfolio in Q1 2026, its #70 holding.
  • Blue Capital Inc first reported a position in AbbVie in Q4 2024 and has held it in 5 quarters since.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Blue Capital Inc's 13F filing for Q1 2026, filed 24 Apr 2026.